SOFIA QADIR: Open Payments
NPI 1659442515 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 20 payments from 9 companies in 2025. Trend: 2023 $1,728 · 2024 $2,102 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $396 |
| Axsome Therapeutics, Inc. | 4 | $160 |
| Luye Pharma (USA) Ltd. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Noven Therapeutics, LLC | 1 | $122 |
| Alkermes, Inc. | 1 | $120 |
| ABBVIE INC. | 5 | $79 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: COBENFY, Auvelity, ERZOFRI EXTENDED-RELEASE, AUSTEDO XR, Xelstrym, LYBALVI, VRAYLAR, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
